Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 1059

1.

Prognostic relevance of CD163 and CD8 combined with EZH2 and gain of chromosome 18 in follicular lymphoma: A study by the Lunenburg Lymphoma Biomarker Consortium.

Stevens WBC, Mendeville M, Redd R, Clear AJ, Bladergroen R, Calaminici M, Rosenwald A, Hoster E, Hiddemann W, Gaulard P, Xerri L, Salles G, Klapper W, Phreundschuh M, Jack A, Gascoyne RD, Natkunam Y, Advani R, Kimby E, Sander B, Sehn L, Hagenbeek A, Raemaekers J, Gribben J, Kersten MJ, Ylstra B, Weller E, de Jong D.

Haematologica. 2017 Apr 14. pii: haematol.2017.165415. doi: 10.3324/haematol.2017.165415. [Epub ahead of print]

2.

Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.

Mejia Otero C, Assassi S, Hudson M, Mayes MD, Estrada-Y-Martin R, Pedroza C, Mills TW, Walker J, Baron M, Stevens W, Proudman SM, Nikpour M, Mehra S, Wang M, Fritzler MJ; Canadian Scleroderma Research Group.; Australian Scleroderma Cohort Study.; Genetics versus Environment in Scleroderma Outcome Study ..

J Rheumatol. 2017 Apr 1. pii: jrheum.160574. doi: 10.3899/jrheum.160574. [Epub ahead of print]

PMID:
28365584
3.

Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease.

Boulos D, Ngian GS, Rajadurai A, Elford K, Stevens W, Proudman S, Owen C, Roddy J, Nikpour M, Youssef P, Hill C, Sahhar J.

Int J Rheum Dis. 2017 Mar 24. doi: 10.1111/1756-185X.13035. [Epub ahead of print]

PMID:
28337853
4.

The Australian Scleroderma Interest Group and database: 10 years of screening to save lives.

Nikpour M, Proudman S, Morrisroe K, Sahhar JM, Stevens W.

Med J Aust. 2017 Mar 20;206(5):229. No abstract available.

PMID:
28301795
5.

Choosing a new CD4 technology: Can statistical method comparison tools influence the decision?

Scott LE, Kestens L, Pattanapanyasat K, Sukapirom K, Stevens WS.

Cytometry B Clin Cytom. 2017 Mar 10. doi: 10.1002/cyto.b.21522. [Epub ahead of print]

PMID:
28296063
6.

Clinical Characteristics of Patients with Chronic Rhinosinusitis with Nasal Polyps, Asthma, and Aspirin-Exacerbated Respiratory Disease.

Stevens WW, Peters AT, Hirsch AG, Nordberg CM, Schwartz BS, Mercer DG, Mahdavinia M, Grammer LC, Hulse KE, Kern RC, Avila P, Schleimer RP.

J Allergy Clin Immunol Pract. 2017 Mar 9. pii: S2213-2198(17)30005-3. doi: 10.1016/j.jaip.2016.12.027. [Epub ahead of print]

PMID:
28286156
7.

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme.

Morrisroe K, Stevens W, Sahhar J, Rabusa C, Nikpour M, Proudman S; Australian Scleroderma Interest Group (ASIG)..

Arthritis Res Ther. 2017 Mar 7;19(1):42. doi: 10.1186/s13075-017-1250-z.

8.

Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.

Takahashi T, Kato A, Berdnikovs S, Stevens WW, Suh LA, Norton JE, Carter RG, Harris KE, Peters AT, Hulse KE, Grammer LC, Welch KC, Shintani-Smith S, Tan BK, Conley DB, Kern RC, Bochner BS, Schleimer RP.

J Allergy Clin Immunol. 2017 Feb 24. pii: S0091-6749(17)30293-2. doi: 10.1016/j.jaci.2017.01.022. [Epub ahead of print]

PMID:
28238741
9.

Delays and loss to follow-up before treatment of drug-resistant tuberculosis following implementation of Xpert MTB/RIF in South Africa: A retrospective cohort study.

Cox H, Dickson-Hall L, Ndjeka N, Van't Hoog A, Grant A, Cobelens F, Stevens W, Nicol M.

PLoS Med. 2017 Feb 21;14(2):e1002238. doi: 10.1371/journal.pmed.1002238. eCollection 2017 Feb.

10.

Implications of failure to routinely diagnose resistance to second-line drugs in patients with rifampicin-resistant tuberculosis on Xpert MTB/RIF: a multisite observational study.

Jacobson KR, Barnard M, Kleinman MB, Streicher EM, Ragan EJ, White LF, Shapira O, Dolby T, Simpson J, Scott L, Stevens W, van Helden PD, Van Rie A, Warren RM.

Clin Infect Dis. 2017 Feb 12. doi: 10.1093/cid/cix128. [Epub ahead of print] No abstract available.

PMID:
28199520
11.

Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).

Herrick AL, Pan X, Peytrignet S, Lunt M, Hesselstrand R, Mouthon L, Silman A, Brown E, Czirják L, Distler JH, Distler O, Fligelstone K, Gregory WJ, Ochiel R, Vonk M, Ancuţa C, Ong VH, Farge D, Hudson M, Matucci-Cerinic M, Balbir-Gurman A, Midtvedt Ø, Jordan AC, Jobanputra P, Stevens W, Moinzadeh P, Hall FC, Agard C, Anderson ME, Diot E, Madhok R, Akil M, Buch MH, Chung L, Damjanov N, Gunawardena H, Lanyon P, Ahmad Y, Chakravarty K, Jacobsen S, MacGregor AJ, McHugh N, Müller-Ladner U, Riemekasten G, Becker M, Roddy J, Carreira PE, Fauchais AL, Hachulla E, Hamilton J, İnanç M, McLaren JS, van Laar JM, Pathare S, Proudman S, Rudin A, Sahhar J, Coppere B, Serratrice C, Sheeran T, Veale DJ, Grange C, Trad GS, Denton CP.

Ann Rheum Dis. 2017 Feb 10. pii: annrheumdis-2016-210503. doi: 10.1136/annrheumdis-2016-210503. [Epub ahead of print]

12.

Impact of the GeneXpert MTB/RIF Technology on Tuberculosis Control.

Stevens WS, Scott L, Noble L, Gous N, Dheda K.

Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TBTB2-0040-2016.

PMID:
28155817
13.

Diagnosis and monitoring of HIV programmes to support treatment initiation and follow up and improve programme quality.

Venter WD, Ford N, Vitoria M, Stevens W.

Curr Opin HIV AIDS. 2017 Mar;12(2):117-122. doi: 10.1097/COH.0000000000000354.

PMID:
28134712
14.

Imputing HIV treatment start dates from routine laboratory data in South Africa: a validation study.

Maskew M, Bor J, Hendrickson C, MacLeod W, Bärnighausen T, Pillay D, Sanne I, Carmona S, Stevens W, Fox MP.

BMC Health Serv Res. 2017 Jan 17;17(1):41. doi: 10.1186/s12913-016-1940-2.

15.

Adolescent and young adult (AYA) lymphoma survivors report lower health-related quality of life compared to a normative population: results from the PROFILES registry.

Husson O, Prins JB, Kaal SE, Oerlemans S, Stevens WB, Zebrack B, van der Graaf WT, van de Poll-Franse LV.

Acta Oncol. 2017 Feb;56(2):288-294. doi: 10.1080/0284186X.2016.1267404. Epub 2017 Jan 12.

PMID:
28077017
16.

Diagnosis of opportunistic infections: HIV co-infections - tuberculosis.

Scott L, da Silva P, Boehme CC, Stevens W, Gilpin CM.

Curr Opin HIV AIDS. 2017 Mar;12(2):129-138. doi: 10.1097/COH.0000000000000345.

PMID:
28059955
17.

The cobas® 6800/8800 System: a new era of automation in molecular diagnostics.

Cobb B, Simon CO, Stramer SL, Body B, Mitchell PS, Reisch N, Stevens W, Carmona S, Katz L, Will S, Liesenfeld O.

Expert Rev Mol Diagn. 2017 Feb;17(2):167-180. doi: 10.1080/14737159.2017.1275962.

PMID:
28043179
18.

Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.

Hao Y, Hudson M, Baron M, Carreira P, Stevens W, Rabusa C, Tatibouet S, Carmona L, Joven BE, Huq M, Proudman S, Nikpour M; Canadian Scleroderma Research Group.; Australian Scleroderma Interest Group..

Arthritis Rheumatol. 2017 May;69(5):1067-1077. doi: 10.1002/art.40027. Epub 2017 Apr 6.

PMID:
28029745
19.

Chronic airway inflammation provides a unique environment for B cell activation and antibody production.

Feldman S, Kasjanski R, Poposki J, Hernandez D, Chen JN, Norton JE, Suh L, Carter RG, Stevens WW, Peters AT, Kern RC, Conley DB, Tan BK, Shintani-Smith S, Welch KC, Grammer LC, Harris KE, Kato A, Schleimer RP, Hulse KE.

Clin Exp Allergy. 2017 Apr;47(4):457-466. doi: 10.1111/cea.12878. Epub 2017 Jan 26.

PMID:
28000955
20.

Discovery of Highly Potent Liver X Receptor β Agonists.

Kick EK, Busch BB, Martin R, Stevens WC, Bollu V, Xie Y, Boren BC, Nyman MC, Nanao MH, Nguyen L, Plonowski A, Schulman IG, Yan G, Zhang H, Hou X, Valente MN, Narayanan R, Behnia K, Rodrigues AD, Brock B, Smalley J, Cantor GH, Lupisella J, Sleph P, Grimm D, Ostrowski J, Wexler RR, Kirchgessner T, Mohan R.

ACS Med Chem Lett. 2016 Oct 23;7(12):1207-1212. eCollection 2016 Dec 8.

PMID:
27994765

Supplemental Content

Loading ...
Support Center